Current price is less than the intrinsic value

Intrinsic value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

Bharat Parenterals consolidated net profit rises 113.76% in the March 2022 quarter

Bharat Parenterals consolidated net profit rises 23.26% in the September 2021 quarter

Bharat Parenterals standalone net profit rises 24.34% in the September 2021 quarter

Bharat Parenterals consolidated net profit rises 16.42% in the June 2021 quarter

Bharat Parenterals consolidated net profit declines 73.49% in the March 2021 quarter

The product patent has been already filed under fast track approval, said Bharat Parenterals.

Bharat Parenterals stock freezes at 5% upper circuit after receiving a license to manufacture Favipiravir

Drug firm Bharat Parenterals on Saturday said it has received approval from the Drugs Controller General of India (DCGI) for favipiravir oral suspension, to be used for treatment of COVID-19 patients.The company has received licence and authorisation from DCGI to manufacture and market fav…

COVID-19: Bharat Parenterals gets DCGI nod for favipiravir oral suspension

​​The company has received licence and authorisation from DCGI to manufacture and market favipiravir oral suspension l00mg/ml, Bharat Parenterals said in a regulatory filing.

Bharat Parenterals gets DCGI nod for favipiravir oral suspension

Bharat Parenterals consolidated net profit declines 32.96% in the December 2020 quarter

The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.

BRIEF-Bharat Parenterals To Sell Stake In Varenyam Healthcare Private Limited - Investing.com India

Bharat Parenterals Limited is a pharmaceutical company that makes pharmaceutical formulations. Its products include general, beta-lactam, cephalosporins, antiretroviral, and veterinary.

Bharat Parenterals Ltd

Bharat Parenterals Ltd

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Bharat Parenterals consolidated net profit rises 113.76% in the March 2022 quarter

Bharat Parenterals consolidated net profit rises 23.26% in the September 2021 quarter

Bharat Parenterals standalone net profit rises 24.34% in the September 2021 quarter

Bharat Parenterals consolidated net profit rises 16.42% in the June 2021 quarter

Bharat Parenterals consolidated net profit declines 73.49% in the March 2021 quarter

Bharat Parenterals stock freezes at 5% upper circuit after receiving a license to manufacture Favipiravir

COVID-19: Bharat Parenterals gets DCGI nod for favipiravir oral suspension

Bharat Parenterals Ltd

Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry pointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Bharat Parenterals consolidated net profit rises 113.76% in the March 2022 quarter

Bharat Parenterals consolidated net profit rises 23.26% in the September 2021 quarter

Bharat Parenterals standalone net profit rises 24.34% in the September 2021 quarter

Bharat Parenterals consolidated net profit rises 16.42% in the June 2021 quarter

Bharat Parenterals consolidated net profit declines 73.49% in the March 2021 quarter

Bharat Parenterals stock freezes at 5% upper circuit after receiving a license to manufacture Favipiravir

COVID-19: Bharat Parenterals gets DCGI nod for favipiravir oral suspension

Intrinsic value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock